Ipriflavone
From Wikipedia, the free encyclopedia
This article or section is in need of attention from an expert on the subject. WikiProject Medicine or the Medicine Portal may be able to help recruit one. |
Ipriflavone
|
|
Systematic (IUPAC) name | |
3-phenyl-7-propan-2-yloxychromen-4-one | |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C18H16O3 |
Mol. mass | 280.318 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Ipriflavone is a synthetic isoflavone which is used to maintain bone density and to prevent osteoporosis in postmenopausal women. It is not used to treat osteoporosis. It slows down the action of the osteoclasts (bone-eroding cells), allowing the osteoblasts (bone-building cells) to build up bone mass.
[edit] External links
- Ipriflavone at PDR Health